Attomolar Detection of Botulinum Toxin Type A in Complex Biological Matrices
Open Access
- 30 April 2008
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 3 (4), e2041
- https://doi.org/10.1371/journal.pone.0002041
Abstract
A highly sensitive, rapid and cost efficient method that can detect active botulinum neurotoxin (BoNT) in complex biological samples such as foods or serum is desired in order to 1) counter the potential bioterrorist threat 2) enhance food safety 3) enable future pharmacokinetic studies in medical applications that utilize BoNTs. Here we describe a botulinum neurotoxin serotype A assay with a large immuno-sorbent surface area (BoNT/A ALISSA) that captures a low number of toxin molecules and measures their intrinsic metalloprotease activity with a fluorogenic substrate. In direct comparison with the “gold standard” mouse bioassay, the ALISSA is four to five orders of magnitudes more sensitive and considerably faster. Our method reaches attomolar sensitivities in serum, milk, carrot juice, and in the diluent fluid used in the mouse assay. ALISSA has high specificity for the targeted type A toxin when tested against alternative proteases including other BoNT serotypes and trypsin, and it detects the holotoxin as well as the multi-protein complex form of BoNT/A. The assay was optimized for temperature, substrate concentration, size and volume proportions of the immuno-sorbent matrix, enrichment and reaction times. Finally, a kinetic model is presented that is consistent with the observed improvement in sensitivity. The sensitivity, specificity, speed and simplicity of the BoNT ALISSA should make this method attractive for diagnostic, biodefense and pharmacological applications.This publication has 57 references indexed in Scilit:
- Iatrogenic Botulism Due to Therapeutic Botulinum Toxin A Injection in a Pediatric PatientClinical Neuropharmacology, 2007
- Trivalent Vaccine against Botulinum Toxin Serotypes A, B, and E That Can Be Administered by the Mucosal RouteInfection and Immunity, 2007
- Molecular evolution of antibody cross-reactivity for two subtypes of type A botulinum neurotoxinNature Biotechnology, 2006
- Enzyme-amplified protein microarray and a fluidic renewable surface fluorescence immunoassay for botulinum neurotoxin detection using high-affinity recombinant antibodiesAnalytica Chimica Acta, 2006
- Human Botulism Immune Globulin for the Treatment of Infant BotulismThe New England Journal of Medicine, 2006
- Detection of Type A, B, E, and F Clostridium botulinum Neurotoxins in Foods by Using an Amplified Enzyme-Linked Immunosorbent Assay with Digoxigenin-Labeled AntibodiesApplied and Environmental Microbiology, 2006
- From the Mouse to the Mass Spectrometer: Detection and Differentiation of the Endoproteinase Activities of Botulinum Neurotoxins A−G by Mass SpectrometryAnalytical Chemistry, 2005
- Deciphering antibody properties that lead to potent botulinum neurotoxin neutralizationMovement Disorders, 2004
- Enhancement of the Endopeptidase Activity of Botulinum Neurotoxin by Its Associated Proteins and DithiothreitolBiochemistry, 1999
- Botulinum neurotoxins serotypes A and E cleave SNAP‐25 at distinct COOH‐terminal peptide bondsFEBS Letters, 1993